Researchers test mRNA technology for universal flu vaccine

Researchers test mRNA technology for universal flu vaccine By Reuters

Breaking News



More


Sign In/Free Sign Up

0

‘;

Stock Markets 3 minutes ago (Nov 25, 2022 06:05PM ET)

(C) Reuters. FILE PHOTO: People enter a pharmacy next to a sign promoting flu shots in New York January 10, 2013. REUTERS/Andrew Kelly/File Photo

By Nancy Lapid

(Reuters) – An experimental vaccine provided broad protection against all 20 known influenza A and B virus subtypes in initial tests in mice and ferrets, potentially opening a pathway to a universal flu shot that might help prevent future pandemics, according to a U.S. study published on Thursday.

The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer (NYSE:PFE) with BioNTech, and by Moderna (NASDAQ:MRNA). It delivers tiny lipid particles containing mRNA instructions for cells to create replicas of so-called hemagglutinin proteins that appear on influenza virus surfaces.

A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.

“The idea here is to have a vaccine that will give people a baseline level of immune memory to diverse flu strains, so that there will be far less disease and death when the next flu pandemic occurs,” study leader Scott Hensley of the Perelman School of Medicine at the University of Pennsylvania said in a statement.

Unlike standard flu vaccines that deliver one or two versions of hemagglutinin, the experimental vaccine includes 20 different types in the hope of getting the immune system to recognize any flu virus it might encounter in the future.

In lab experiments, vaccinated animals’ immune systems recognized the hemagglutinin proteins and defended against 18 different strains of influenza A and two strains of influenza B. Antibody levels induced by the vaccine remained unchanged for at least four months, according to a report published in the journal Science.

The vaccine reduced signs of illness and protected from death even when the ferrets were exposed to a different type of flu not in the vaccine, the researchers said.

Moderna and Pfizer both have mRNA flu vaccines in late-stage human trials, and GSK and partner CureVac are testing an mRNA flu vaccine in an early-stage safety trial in humans. These vaccines are designed to defend against only four recently-circulating influenza strains but could theoretically be changed up each year.

The universal flu vaccine, if successful in human trials, would not necessarily prevent infection. The goal is to provide durable protection against severe disease and death, Hensley said.

Questions remain regarding how to judge efficacy and potential regulatory requirements for a vaccine against possible future viruses that are not currently circulating, Alyson Kelvin and Darryl Falzarano of the University of Saskatchewan, Canada, wrote in a commentary published with the study.

While the promising results with the new vaccine “suggest a protective capacity against all subtypes of influenza viruses, we cannot be sure until clinical trials in volunteers are done,” Adolfo Garc?a-Sastrem, director of the Institute for Global Health and Emerging Pathogens at Mount Sinai Hospital in New York, said in a statement.

Researchers test mRNA technology for universal flu vaccine

Nasdaq ends down as investors eye Black Friday sales, China infectionsBy Reuters – Nov 25, 2022

By Carolina Mandl and Ankika Biswas (Reuters) – The Nasdaq closed lower on Friday with pressure from Apple Inc (NASDAQ:AAPL) in a subdued holiday-shortened trading session for…

Black Friday crowds thin despite dealsBy Reuters – Nov 25, 2022

By Arriana McLymore and Doyinsola Oladipo RALEIGH, N.C./ NEW YORK (Reuters) – Inflation-weary shoppers were expected to turn out in record numbers for deals on Black Friday. But…

Walmart gunman railed at co-workers in ‘death note’ before Virginia store shootingBy Reuters – Nov 25, 2022

By Nathan Layne (Reuters) -A Walmart (NYSE:WMT) supervisor who killed six co-workers at a store in Virginia on Tuesday bought a handgun the day of the shooting and left a rambling…

Trade With A Regulated Broker


Our Apps



READ ALSO

Terms And Conditions
Privacy Policy
Risk Warning

(C) 2007-2022 Fusion Media Limited. All Rights Reserved.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Related Posts

Next Post
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    POPULAR NEWS

    No Content Available